Insider · CIK 0001616640

AGARWAL SUNIL

Reports to the SEC for 7 companies · BOSTON, MA

sec.gov

Transactions

Companies

Filings

CIK

0001616640

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-01-23	ATXSAstria Therapeutics, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−26.6K sh	—	—	0
2026-01-23	ATXSAstria Therapeutics, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−28.2K sh	—	—	0
2025-06-25	ARVNARVINAS, INC. · Stock Option (right to buy)A Award	Director	AAward	+23.1K sh	—	—	23,105
2025-06-25	ARVNARVINAS, INC.A Award	Director	AAward	+16K sh	—	—	30,166
2025-06-11	ATXSAstria Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+26.6K sh	—	—	26,550
2024-05-29	ARVNARVINAS, INC. · Stock Option (right to buy)A Award	Director	AAward	+9,070 sh	—	—	9,070
2024-05-29	ARVNARVINAS, INC.A Award	Director	AAward	+5,899 sh	—	—	14,141
2024-04-08	ATXSAstria Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+28.2K sh	—	—	28,200
2023-06-15	ARVNARVINAS, INC. · Stock Option (right to buy)A Award	Director	AAward	+24.9K sh	—	—	24,948
2023-06-15	ARVNARVINAS, INC.A Award	Director	AAward	+8,242 sh	—	—	8,242
2022-06-01	Calithera Biosciences, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+20K sh	—	—	20,000
2022-03-03	SANASana Biotechnology, Inc. · Stock Options (Right to Buy)A Award	EVP, Head of Development & CMO	AAward	+250K sh	—	—	250,000
2021-09-16	SANASana Biotechnology, Inc.S Sale	EVP, Head of Development & CMO	SSale	−1,627 sh	$26.00	−$42.3K	1,550,000
2021-09-15	SANASana Biotechnology, Inc.S Sale	EVP, Head of Development & CMO	SSale	−58.4K sh	$26.07	−$1.52M	1,551,627
2021-06-11	Calithera Biosciences, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+20K sh	—	—	20,000
2021-02-03	SANASana Biotechnology, Inc. · Stock Option (Right to Buy)A Award	EVP, Head of Development & CMO	AAward	+48K sh	—	—	48,000
2021-02-03	SANASana Biotechnology, Inc. · Stock Option (Right to Buy)A Award	EVP, Head of Development & CMO	AAward	+76.7K sh	—	—	76,682
2020-11-17	MyoKardia, Inc.Stock Option (Right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−22K sh	—	—	0
2020-11-17	MyoKardia, Inc.U Disposition from Tender	Director	UDisposition from Tender	−4,100 sh	—	—	0
2020-11-17	MyoKardia, Inc.Stock Option (Right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−11K sh	—	—	0
2020-11-17	MyoKardia, Inc.Stock Option (Right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−11K sh	—	—	0
2020-11-17	MyoKardia, Inc.Stock Option (Right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−11K sh	—	—	0
2020-11-17	MyoKardia, Inc.Stock Option (Right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−6,600 sh	—	—	0
2020-11-17	MyoKardia, Inc.Stock Option (Right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−3,000 sh	—	—	0
2020-06-18	MyoKardia, Inc.Restricted Stock UnitsA Award	Director	AAward	+1,800 sh	—	—	1,800
2020-06-18	MyoKardia, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+3,000 sh	—	—	3,000
2020-06-13	MyoKardia, Inc.Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	+2,300 sh	—	—	0
2020-06-13	MyoKardia, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+2,300 sh	—	—	2,300
2020-06-13	MyoKardia, Inc.Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−2,300 sh	—	—	0
2020-06-13	MyoKardia, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+2,300 sh	—	—	2,300
2020-06-09	Calithera Biosciences, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+20K sh	—	—	20,000
2019-06-13	MyoKardia, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+6,600 sh	—	—	6,600
2019-06-13	MyoKardia, Inc.Restricted Stock UnitsA Award	Director	AAward	+2,300 sh	—	—	2,300
2019-05-30	Calithera Biosciences, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+11K sh	—	—	11,000
2018-06-12	MyoKardia, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+11K sh	—	—	11,000
2018-05-31	Calithera Biosciences, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+11K sh	—	—	11,000
2018-03-05	Juno Therapeutics, Inc.Employee Stock Option (Right to Buy)D Disposition to Issuer	President of R & D	DDisposition to Issuer	−314K sh	—	—	0
2018-03-05	Juno Therapeutics, Inc.D Disposition to Issuer	President of R & D	DDisposition to Issuer	−84.5K sh	—	—	65,028
2018-03-05	Juno Therapeutics, Inc.D Disposition to Issuer	President of R & D	DDisposition to Issuer	−29.1K sh	—	—	35,893
2018-03-05	Juno Therapeutics, Inc.D Disposition to Issuer	President of R & D	DDisposition to Issuer	−35.9K sh	—	—	0
2018-01-31	Juno Therapeutics, Inc.A Award	President of R & D	AAward	+29.1K sh	—	—	149,577
2017-10-20	Juno Therapeutics, Inc.A Award	President of R & D	AAward	+35.9K sh	—	—	120,442
2017-10-02	Juno Therapeutics, Inc.S Sale	President of R & D	SSale	−7,285 sh	$44.76	−$326K	84,549
2017-06-14	MyoKardia, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+11K sh	—	—	11,000
2017-06-09	Calithera Biosciences, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+11K sh	—	—	11,000
2017-04-13	Juno Therapeutics, Inc.A Award	President of R & D	AAward	+96.6K sh	—	—	96,627
2017-04-13	Juno Therapeutics, Inc.Stock Option (Right to Buy)A Award	President of R & D	AAward	+314K sh	—	—	313,797
2017-04-13	Juno Therapeutics, Inc.F Tax Payment	President of R & D	FTax Payment	−4,793 sh	$24.01	−$115K	91,834
2016-08-19	RAREUltragenyx Pharmaceutical Inc.F Tax Payment	Chief Medical Officer	FTax Payment	−392 sh	$66.00	−$25.9K	9,136
2016-07-21	RAREUltragenyx Pharmaceutical Inc.S Sale	Chief Medical Officer	SSale	−649 sh	$52.68	−$34.2K	9,528

Recent filings

Accepted (ET)
Jan 234
AGARWAL SUNIL0000905148-26-000311
SEC(opens sec.gov)
Jun 304
AGARWAL SUNIL0001655759-25-000126
SEC(opens sec.gov)
Jun 124
AGARWAL SUNIL0001104659-25-059044
SEC(opens sec.gov)
May 314
AGARWAL SUNIL0001655759-24-000084
SEC(opens sec.gov)
Apr 94
AGARWAL SUNIL0001104659-24-045003
SEC(opens sec.gov)
Jun 204
AGARWAL SUNIL0001655759-23-000059
SEC(opens sec.gov)
Jun 34
AGARWAL SUNIL0000899243-22-020933
SEC(opens sec.gov)
Mar 84
AGARWAL SUNIL0001562180-22-002429
SEC(opens sec.gov)
Sep 174
AGARWAL SUNIL0001562180-21-005999
SEC(opens sec.gov)
Jun 144
AGARWAL SUNIL0000899243-21-023535
SEC(opens sec.gov)
Feb 184/A
AGARWAL SUNIL0000899243-21-007181
SEC(opens sec.gov)
Feb 54
AGARWAL SUNIL0000899243-21-005080
SEC(opens sec.gov)
Nov 194
AGARWAL SUNIL0000899243-20-031758
SEC(opens sec.gov)

Companies

Address

C/O ASTRIA THERAPEUTICS, INC. 22 BOSTON WHARF ROAD, 10TH FLOOR

BOSTON, MA, 02210